A New Minimal-invasive Brain Tissue Probe Applying Near Infrared Spectroscopy

Spontaneous Subarachnoid Hemorrhage Clinical Trial

Official title:
A New Multi-parameter Monitoring System Applying Near Infrared Spectroscopy and Indocyanine Green to Detect Cerebrovascular Events in Patients With Subarachnoid Hemorrhage

Status Completed

Clinical Trial Summary

To assess the feasibility of a new brain tissue probe for multi-parameter neuromonitoring (NeMo Probe) and the accuracy of measurement values.

To demonstrate the ability of the NeMo probe to detect changes in cerebral hemodynamics and oxygenation during cerebrovascular events monitored with established methods including brain tissue oxygenation tension and microdialysis

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Hemorrhage
Spontaneous Subarachnoid Hemorrhage
Subarachnoid Hemorrhage

Clinical Trial Details

NCT number	NCT01801306
Study type	Interventional
Source	NeMoDevices AG
Contact
Status	Completed
Phase	N/A
Start date	March 2013
Completion date	February 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04377347` - Long-term Effects of Time to Treatment in Subarachnoid Haemorrhage
Completed	`NCT03786068` - Time to Specialized Admission in Case of Severe Brain Haemorrhage.
Recruiting	`NCT00173095` - The Bilirubin Levels in Cerebrospinal Fluid of Spontaneous Subarachnoid Hemorrhage Patients	N/A
Not yet recruiting	`NCT06439615` - Baricitinib for the Lung Injury Following Spontaneous SAH	Phase 2